{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:38:03Z","timestamp":1792730283459,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005205","name":"J&J Innovative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.expneurol.2026.116014","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:14:06Z","timestamp":1788963246000},"page":"116014","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["JNJ-42153605, a mGluR2 PAM, potentiates levetiracetam treatments of TBI to mitigate subsequent tau aggregation in a larval zebrafish model"],"prefix":"10.1016","volume":"407","author":[{"given":"Laszlo F.","family":"Locskai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayleen","family":"Ghassemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha A.W.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa J.","family":"Kinley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Ted","family":"Allison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.expneurol.2026.116014_bb0005","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2147\/NDT.S2937","article-title":"Levetiracetam in the treatment of epilepsy","volume":"4","author":"Abou-Khalil","year":"2008","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.expneurol.2026.116014_bb0010","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.58744","article-title":"Seizures are a druggable mechanistic link between TBI and subsequent tauopathy","volume":"10","author":"Alyenbaawi","year":"2021","journal-title":"Elife"},{"issue":"11\u221212","key":"10.1016\/j.expneurol.2026.116014_bb0015","doi-asserted-by":"crossref","first-page":"e3570","DOI":"10.1093\/milmed\/usad192","article-title":"Use of levetiracetam for post-traumatic seizure prophylaxis in combat-related traumatic brain injury","volume":"188","author":"Atwood","year":"2023","journal-title":"Mil. Med."},{"issue":"6","key":"10.1016\/j.expneurol.2026.116014_bb0020","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1089\/neu.2015.4131","article-title":"Levetiracetam treatment in traumatic brain injury: operation brain trauma therapy","volume":"33","author":"Browning","year":"2016","journal-title":"J. Neurotrauma"},{"issue":"2","key":"10.1016\/j.expneurol.2026.116014_bb0025","first-page":"257","article-title":"Neuroprotection and anti-seizure effects of levetiracetam in a rat model of penetrating ballistic-like brain injury","volume":"34","author":"Caudle","year":"2016","journal-title":"Restor. Neurol. Neurosci."},{"key":"10.1016\/j.expneurol.2026.116014_bb0030","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.brainres.2016.04.013","article-title":"Levetiracetam prophylaxis ameliorates seizure epileptogenesis after fluid percussion injury","volume":"1642","author":"Chen","year":"2016","journal-title":"Brain Res."},{"issue":"18","key":"10.1016\/j.expneurol.2026.116014_bb0035","doi-asserted-by":"crossref","first-page":"8495","DOI":"10.1021\/acs.jmedchem.6b00913","article-title":"Discovery of 8-Trifluoromethyl-3-cyclopropylmethyl-7-[(4-(2,4-difluorophenyl)-1-piperazinyl)methyl]-1,2,4-triazolo[4,3-a]pyridine (JNJ-46356479), a selective and orally bioavailable mGlu2 receptor positive allosteric modulator (PAM)","volume":"59","author":"Cid","year":"2016","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.expneurol.2026.116014_bb0040","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.yebeh.2003.07.008","article-title":"Aggressive behavior of epilepsy patients in the course of levetiracetam add-on therapy: report of 33 mild to severe cases","volume":"4","author":"Dinkelacker","year":"2003","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.expneurol.2026.116014_bb0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-0716-3401-1_1","article-title":"Delivering traumatic brain injury to larval zebrafish","volume":"2707","author":"Gill","year":"2024","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.expneurol.2026.116014_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2023.114545","article-title":"Low dose of levetiracetam counteracts amyloid beta-induced alterations of hippocampal gamma oscillations by restoring fast-spiking interneuron activity","volume":"369","author":"Isla","year":"2023","journal-title":"Exp. Neurol."},{"issue":"5","key":"10.1016\/j.expneurol.2026.116014_bb0055","first-page":"732","article-title":"Use of levetiracetam in prophylaxis of early post-traumatic seizures","volume":"26","author":"Javed","year":"2016","journal-title":"Turk. Neurosurg."},{"issue":"4","key":"10.1016\/j.expneurol.2026.116014_bb0060","doi-asserted-by":"crossref","DOI":"10.3171\/FOC.2008.25.10.E3","article-title":"Levetiracetam versus phenytoin for seizure prophylaxis in severe traumatic brain injury","volume":"25","author":"Jones","year":"2008","journal-title":"Neurosurg. Focus"},{"issue":"1","key":"10.1016\/j.expneurol.2026.116014_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40263-023-01058-9","article-title":"Effect of levetiracetam on cognition: a systematic review and Meta-analysis of double-blind randomized placebo-controlled trials","volume":"38","author":"Lin","year":"2024","journal-title":"CNS Drugs"},{"key":"10.1016\/j.expneurol.2026.116014_bb0070","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1146\/annurev-pharmtox-051921-013930","article-title":"Antiepileptic drugs as potential dementia prophylactics following traumatic brain injury","volume":"64","author":"Locskai","year":"2024","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"2","key":"10.1016\/j.expneurol.2026.116014_bb0075","doi-asserted-by":"crossref","DOI":"10.1242\/bio.060601","article-title":"A larval zebrafish model of traumatic brain injury: optimizing the dose of neurotrauma for discovery of treatments and aetiology","volume":"14","author":"Locskai","year":"2025","journal-title":"Biol. Open"},{"issue":"9","key":"10.1016\/j.expneurol.2026.116014_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsps.2023.101728","article-title":"Impact of levetiracetam on cognitive impairment, neuroinflammation, oxidative stress, and neuronal apoptosis caused by lipopolysaccharides in rats","volume":"31","author":"Mani","year":"2023","journal-title":"Saudi Pharm. J."},{"issue":"3","key":"10.1016\/j.expneurol.2026.116014_bb0085","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/epi.13659","article-title":"Efficacy of mGlu(2) -positive allosteric modulators alone and in combination with levetiracetam in the mouse 6 Hz model of psychomotor seizures","volume":"58","author":"Metcalf","year":"2017","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.expneurol.2026.116014_bb0090","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/epi.14005","article-title":"Potent and selective pharmacodynamic synergy between the metabotropic glutamate receptor subtype 2-positive allosteric modulator JNJ-46356479 and levetiracetam in the mouse 6-Hz (44-mA) model","volume":"59","author":"Metcalf","year":"2018","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.expneurol.2026.116014_bb0095","doi-asserted-by":"crossref","first-page":"18","DOI":"10.15844\/pedneurbriefs-30-3-1","article-title":"Levetiracetam for Pediatric posttraumatic seizure prophylaxis","volume":"30","author":"Nita","year":"2016","journal-title":"Pediatr. Neurol. Briefs"},{"issue":"9","key":"10.1016\/j.expneurol.2026.116014_bb0100","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1111\/epi.12326","article-title":"Results of phase II levetiracetam trial following acute head injury in children at risk for posttraumatic epilepsy","volume":"54","author":"Pearl","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.expneurol.2026.116014_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2023.137080","article-title":"BCI-838, an orally active mGluR2\/3 receptor antagonist pro-drug, rescues learning behavior deficits in the PS19 MAPT","volume":"797","author":"Perez-Garcia","year":"2023","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.expneurol.2026.116014_bb0110","article-title":"High-frequency oscillations in epileptic and non-epileptic Alzheimer's disease patients and the differential effect of levetiracetam on the oscillations","volume":"7","author":"Shandilya","year":"2025","journal-title":"Brain Commun."},{"issue":"3","key":"10.1016\/j.expneurol.2026.116014_bb0115","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s13311-023-01361-9","article-title":"Acute treatment with the M-channel (Kv7, KCNQ) opener retigabine reduces the long-term effects of repetitive blast traumatic brain injuries","volume":"20","author":"Vigil","year":"2023","journal-title":"Neurotherapeutics"},{"issue":"11","key":"10.1016\/j.expneurol.2026.116014_bb0120","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1001\/jamaneurol.2021.3310","article-title":"Effect of levetiracetam on cognition in patients with Alzheimer disease with and without epileptiform activity: a randomized clinical trial","volume":"78","author":"Vossel","year":"2021","journal-title":"JAMA Neurol."},{"issue":"4\u20135","key":"10.1016\/j.expneurol.2026.116014_bb0125","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/15458547261469710","article-title":"High-precision pneumatic induction of traumatic brain injury in larval zebrafish","volume":"23","author":"Wang","year":"2026","journal-title":"Zebrafish"},{"issue":"9","key":"10.1016\/j.expneurol.2026.116014_bb0130","article-title":"Seizure prophylaxis in traumatic brain injury: a comparative study of levetiracetam and phenytoin cerebrospinal fluid levels in trauma patients with signs of increased intracranial pressure requiring ventriculostomy","volume":"11","author":"Zampella","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.expneurol.2026.116014_bb0135","article-title":"Connectivity mapping using a novel sv2a loss-of-function zebrafish epilepsy model as a powerful strategy for anti-epileptic drug discovery","volume":"15","author":"Zhang","year":"2022","journal-title":"Front. Mol. Neurosci."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488626003808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488626003808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:59:25Z","timestamp":1792727965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488626003808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":27,"alternative-id":["S0014488626003808"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2026.116014","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"JNJ-42153605, a mGluR2 PAM, potentiates levetiracetam treatments of TBI to mitigate subsequent tau aggregation in a larval zebrafish model","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2026.116014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116014"}}